17 September 2019 - Deborah Wilkes
Archived
Aytu BioScience is entering the consumer healthcare market by acquiring fellow US company Innovus Pharmaceuticals in a cash and shares deal worth up to USD24 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.